Cysteamine Alleviates Early Brain Injury Via Reducing Oxidative Stress and Apoptosis in a Rat Experimental Subarachnoid Hemorrhage Model

Cellular and Molecular Neurobiology

Volumn 35, Issue 4, 2015, Pages 543-553

  Zhang, Zong yong ^a   Yang, Ming feng ^a   Wang, Tao ^a   Li, Da wei ^a   Liu, Yun lin ^a   Zhang, Jin hui ^a   Sun, Bao liang ^a  

^a TAISHAN MEDICAL UNIVERSITY   (China)

Author keywords

Cysteamine; Early brain injury; Subarachnoid hemorrhage

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; MERCAPTAMINE; REACTIVE OXYGEN METABOLITE;

ANIMAL; ANIMAL BEHAVIOR; APOPTOSIS; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN EDEMA; BRAIN INJURIES; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PERMEABILITY; SPRAGUE DAWLEY RAT; SUBARACHNOID HEMORRHAGE; TUNEL ASSAY;

ANIMALS; APOPTOSIS; BEHAVIOR, ANIMAL; BLOOD-BRAIN BARRIER; BRAIN EDEMA; BRAIN INJURIES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASPASE 3; CEREBRAL CORTEX; CYSTEAMINE; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; IN SITU NICK-END LABELING; MALE; OXIDATIVE STRESS; PERMEABILITY; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SUBARACHNOID HEMORRHAGE;

EID: 84930872887     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-014-0150-x     Document Type: Article

References (21)

1. Ayer RE, Zhang JH (2008) Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm. Acta Neurochir Suppl 104:33–41
2. Barry C, Turner RJ, Corrigan F, Vink R (2012) New therapeutic approaches to subarachnoid hemorrhage. Expert Opin Investig Drugs 21(6):845–859. doi:10.1517/13543784.2012.683113
3. Besouw M, Masereeuw R, van den Heuvel L, Levtchenko E (2013) Cysteamine: an old drug with new potential. Drug Discov Today 18(15–16):785–792. doi:10.1016/j.drudis.2013.02.003
4. Borrell-Pages M, Canals JM, Cordelieres FP, Parker JA, Pineda JR, Grange G, Bryson EA, Guillermier M, Hirsch E, Hantraye P, Cheetham ME, Neri C, Alberch J, Brouillet E, Saudou F, Humbert S (2006) Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. J Clin Investig 116(5):1410–1424. doi:10.1172/JCI27607
5. Dubinsky R, Gray C (2006) CYTE-I-HD: phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington’s disease. Mov Disord 21(4):530–533. doi:10.1002/mds.20756
6. Friedrich V, Flores R, Sehba FA (2012) Cell death starts early after subarachnoid hemorrhage. Neurosci Lett 512(1):6–11. doi:10.1016/j.neulet.2012.01.036
7. Goggi J, Pullar IA, Carney SL, Bradford HF (2003) Signalling pathways involved in the short-term potentiation of dopamine release by BDNF. Brain Res 968(1):156–161
8. Gomis P, Graftieaux JP, Sercombe R, Hettler D, Scherpereel B, Rousseaux P (2010) Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage. J Neurosurg 112(3):681–688. doi:10.3171/2009.4.JNS081377
9. Hunyady B, Palkovits M, Mozsik G, Molnar J, Feher K, Toth Z, Zolyomi A, Szalayova I, Key S, Sibley DR, Mezey E (2001) Susceptibility of dopamine D5 receptor targeted mice to cysteamine. J Physiol Paris 95(1–6):147–151
10. Kessler A, Biasibetti M, Da Silva Melo DA, Wajner M, Dutra-Filho CS, De Souza Wyse AT, Wannmacher CM (2008a) Antioxidant effect of cysteamine in brain cortex of young rats. Neurochem Res 33(5):737–744. doi:10.1007/s11064-007-9486-7
11. Kessler A, Biasibetti M, Feksa LR, Rech VC, Melo DA, Wajner M, Dutra-Filho CS, Wyse AT, Wannmacher CM (2008b) Effects of cysteamine on oxidative status in cerebral cortex of rats. Metab Brain Dis 23(1):81–93. doi:10.1007/s11011-007-9078-x
12. Kutiyanawalla A, Terry AV Jr, Pillai A (2011) Cysteamine attenuates the decreases in TrkB protein levels and the anxiety/depression-like behaviors in mice induced by corticosterone treatment. PLoS One 6(10):e26153. doi:10.1371/journal.pone.0026153
13. Pillai A, Veeranan-Karmegam R, Dhandapani KM, Mahadik SP (2008) Cystamine prevents haloperidol-induced decrease of BDNF/TrkB signaling in mouse frontal cortex. J Neurochem 107(4):941–951. doi:10.1111/j.1471-4159.2008.05665.x
14. Pinto JT, Khomenko T, Szabo S, McLaren GD, Denton TT, Krasnikov BF, Jeitner TM, Cooper AJ (2009) Measurement of sulfur-containing compounds involved in the metabolism and transport of cysteamine and cystamine. Regional differences in cerebral metabolism. J Chromatogr B 877(28):3434–3441. doi:10.1016/j.jchromb.2009.05.041
15. Sehba FA, Hou J, Pluta RM, Zhang JH (2012) The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol 97(1):14–37. doi:10.1016/j.pneurobio.2012.02.003
16. Shieh CH, Hong CJ, Huang YH, Tsai SJ (2008) Potential antidepressant properties of cysteamine on hippocampal BDNF levels and behavioral despair in mice. Prog Neuropsychopharmacol Biol Psychiatry 32(6):1590–1594. doi:10.1016/j.pnpbp.2008.06.003
17. Sun BL, Shen FP, Wu QJ, Chi SM, Yang MF, Yuan H, Xie FM, Zhang YB, Chen J, Zhang F (2010a) Intranasal delivery of calcitonin gene-related peptide reduces cerebral vasospasm in rats. Front Biosci 2:1502–1513
18. Sun L, Xu S, Zhou M, Wang C, Wu Y, Chan P (2010b) Effects of cysteamine on MPTP-induced dopaminergic neurodegeneration in mice. Brain Res 1335:74–82. doi:10.1016/j.brainres.2010.03.079
19. van Gijn J, Kerr RS, Rinkel GJ (2007) Subarachnoid haemorrhage. Lancet 369(9558):306–318. doi:10.1016/S0140-6736(07)60153-6
20. Zhang S, Wang L, Liu M, Wu B (2010) Tirilazad for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2:CD006778. doi:10.1002/14651858.CD006778.pub2
21. Zhang ZY, Sun BL, Yang MF, Li DW, Fang J, Zhang S (2014) Carnosine attenuates early brain injury through its antioxidative and anti-apoptotic effects in a rat experimental subarachnoid hemorrhage model. Cell Mol Neurobiol. doi:10.1007/s10571-014-0106-1